Eugene Myron Holuka
Known title: DirectorCIK: 0001678292
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
CTXR to Attend Investor Conferences in Oct 2026. Citius Pharmaceuticals will attend investor conferences in October 2026, allowing shareholders to hear about future plans. The event may raise the company’s visibility and give management a platform to discuss strategy. The announcement does not alter current trading levels but could affect investor interest.
Transaction History
| CTOR | ▲ Buy | Grant | 300,000 | $0 | 9/19/2025 | View on chart |
| CTXR | ▼ Sell | Tax Withholding | 48 | $36 | 3/13/2024 | View on chart |
| CTXR | ▲ Buy | Option Exercise | 2,415 | $36 | 3/13/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
CTOR to Join October 2026 Investor Conferences
Citius Oncology announced it will take part in investor conferences scheduled for October 2026. The events give the company a platform to present its pipeline and business updates to potential investors. The stock is currently trading near its long‑term support level, which may be observed by attendees.
CTOR to Join October 2026 Investor Conferences. Citius Oncology announced it will take part in investor conferences scheduled for October 2026. The events give the company a platform to present its pipeline and business updates to potential investors. The stock is currently trading near its long‑term support level, which may be observed by attendees.